The effect of gadolinium chelate contrast agent on diffusion-weighted imaging of pancreatic ductal adenocarcinoma

Acta Radiologica

Volumn 54, Issue 4, 2013, Pages 364-368

  Liu, Kefu ^a   Peng, Weijun ^a   Zhou, Zhengrong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Diffusion weighted imaging; Gadolinium chelate contrast agent; Pancreatic ductal adenocarcinoma

Indexed keywords

CHELATION; GADOLINIUM;

APPARENT DIFFUSION COEFFICIENT; CONTRAST AGENT; DIFFUSION WEIGHTED IMAGING; DUCTAL ADENOCARCINOMAS; INTRAVENOUS CONTRAST; SIGNALTONOISE RATIO (SNR); SIGNIFICANT DIFFERENCES; STATISTICALLY SIGNIFICANT DIFFERENCE;

DIFFUSION;

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADENOCARCINOMA; COMPARATIVE STUDY; DIAGNOSTIC USE; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROCEDURES; SIGNAL NOISE RATIO;

ADENOCARCINOMA; CARCINOMA, PANCREATIC DUCTAL; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SIGNAL-TO-NOISE RATIO;

EID: 84880665021     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1177/0284185112471795     Document Type: Article

References (25)

1. Kinner S, Umutlu L, Blex S, et al. Diffusion weighted MR imaging in patients with HCC and liver cirrhosis after administration of different gadolinium contrast agents: is it still reliable? Eur J Radiol 2012;81:e625-8
2. Benndorf M, Schelhorn J, Dietzel M, et al. Diffusion weighted imaging of liver lesions suspect for metastases: Apparent diffusion coefficient (ADC) values and lesion contrast are independent from Gd-EOB-DTPA administration. Eur J Radiol 2012;81:849-53
3. Cui XY, Chen HW, Cai S, et al. Diffusion-weighted MR imaging for detection of extrahepatic cholangiocarcinoma. Eur J Radiol 2012;81:2961-5
4. Le Moigne F, Durieux M, Bancel B, et al. Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver. Magn Reson Imaging 2012;30:656-65
5. Takahara T, Kwee TC. Low b-value diffusion-weighted imaging: Emerging applications in the body. J Magn Reson Imaging 2012;35:1266-73
6. Haradome H, Grazioli L, Morone M, et al. T2-weighted and diffusion-weighted MRI for discriminating benign from malignant focal liver lesions: Diagnostic abilities of single versus combined interpretations. J Magn Reson Imaging 2012;35:1388-96
7. Wiggermann P, Grutzmann R, Weissenbock A, et al. Apparent diffusion coefficient measurements of the pancreas, pancreas carcinoma, and mass-forming focal pancreatitis. Acta Radiol 2012;53:135-9
8. Hayano K, Miura F, Amano H, et al. Correlation of apparent diffusion coefficient measured by diffusion-weighted MRI and clinicopathologic features in pancreatic cancer patients. J Hepatobiliary Pancreat Sci 2012 [Epub ahead of print]
9. Huang WC, Sheng J, Chen SY, et al. Differentiation between pancreatic carcinoma and mass-forming chronic pancreatitis: usefulness of high b value diffusion-weighted imaging. J Dig Dis 2011;12:401-8
10. Jang KM, Kim SH, Kim YK, et al. Imaging features of small (
11. Hur BY, Lee JM, Lee JE, et al. Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: Comparison with pancreatic adenocarcinoma. J Magn Reson Imaging 2012;36:188-97
12. Muhi A, Ichikawa T, Motosugi U, et al. Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging 2012;35:827-36
13. Fukukura Y, Takumi K, Kamimura K, et al. Pancreatic adenocarcinoma: variability of diffusion-weighted MR imaging findings. Radiology 2012;263:732-40
14. Brenner R, Metens T, Bali M, et al. Pancreatic neuroendocrine tumor: Added value of fusion of T2-weighted imaging and high b-value diffusion-weighted imaging for tumor detection. Eur J Radiol 2012;81:e746-9
15. Gulani V, Willatt JM, Blaimer M, et al. Effect of contrast media on single-shot echo planar imaging: implications for abdominal diffusion imaging. J Magn Reson Imaging 2009;30:1203-8
16. Chiu FY, Jao JC, Chen CY, et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. J Comput Assist Tomogr 2005;29:176-80
17. Choi SA, Lee SS, Jung IH, et al. The effect of gadoxetic acid enhancement on lesion detection and characterisation using T(2) weighted imaging and diffusion weighted imaging of the liver. Br J Radiol 2012;85:29-36
18. Wang CL, Chea YW, Boll DT, et al. Effect of gadolinium chelate contrast agents on diffusion weighted MR imaging of the liver, spleen, pancreas and kidney at 3 T. Eur J Radiol 2011;80:e1-7
19. Yamada K, Kubota H, Kizu O, et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted images: evaluation of normal brain and infarcts. Stroke 2002;33:1799-802
20. Ogura A, Hayakawa K, Miyati T, et al. The effect of susceptibility of gadolinium contrast media on diffusion-weighted imaging and the apparent diffusion coefficient. Acad Radiol 2008;15:867-72
21. Firat AK, Sanli B, Karakas HM, et al. The effect of intravenous gadolinium-DTPA on diffusion-weighted imaging. Neuroradiology 2006;48:465-70
22. Wang Y, Chen ZE, Nikolaidis P, et al. Diffusion-weighted magnetic resonance imaging of pancreatic adenocarcinomas: association with histopathology and tumor grade. J Magn Reson Imaging 2011;33:136-42
23. Low G, Panu A, Millo N, Leen E. Multimodality imaging of neoplastic and nonneoplastic solid lesions of the pancreas. Radiographics 2011;31:993-1015
24. Laissy JP, Menegazzo D, Dumont E, et al. Hemodynamic effect of iodinated high-viscosity contrast medium in the rat kidney: a diffusion-weighted MRI feasibility study. Invest Radiol 2000;35:647-52
25. Jost G, Lenhard DC, Sieber MA, et al. Changes of renal water diffusion coefficient after application of iodinated contrast agents: effect of viscosity. Invest Radiol 2011;46:796-800